Want to see AXGN full AI Analyst Report?
Total Valuation
AxoGen has a market cap or net worth of $2.59B. The enterprise value is $2.37K.
Market Cap$2.59B
Enterprise Value$2.37K
Share Statistics
AxoGen has 53,761,513 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,761,513
Owned by Insiders1.56%
Owned by Institutions13.31%
Financial Efficiency
AxoGen’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -3.91%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-3.91%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee362.07K
Profits Per Employee-25.25K
Employee Count622
Asset Turnover1.02
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of AxoGen is ―. AxoGen’s PEG ratio is -2.01.
PE Ratio―
PS Ratio6.69
PB Ratio11.70
Price to Fair Value11.70
Price to FCF-513.89
Price to Operating Cash Flow277.46
PEG Ratio-2.01
Income Statement
In the last 12 months, AxoGen had revenue of 225.21M and earned -15.70M in profits. Earnings per share was -0.34.
Revenue225.21M
Gross Profit167.35M
Operating Income-7.85M
Pretax Income-15.70M
Net Income-15.70M
EBITDA192.00K
Earnings Per Share (EPS)-0.34
Cash Flow
In the last 12 months, operating cash flow was 9.32M and capital expenditures -6.79M, giving a free cash flow of 2.53M billion.
Operating Cash Flow9.32M
Free Cash Flow2.53M
Free Cash Flow per Share0.05
Dividends & Yields
AxoGen pays an annual dividend of $1, resulting in a dividend yield of ―
Dividend Per Share$1
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change228.46%
50-Day Moving Average42.76
200-Day Moving Average35.10
Relative Strength Index (RSI)69.83
Average Volume (3m)1.43M
Important Dates
AxoGen upcoming earnings date is Nov 10, 2026, After Close (Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
AxoGen as a current ratio of 5.11, with Debt / Equity ratio of 7.83%
Current Ratio5.11
Quick Ratio3.31
Debt to Market Cap0.03
Net Debt to EBITDA167.09
Interest Coverage Ratio-1.02
Taxes
In the past 12 months, AxoGen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AxoGen EV to EBITDA ratio is 8.02K, with an EV/FCF ratio of -524.82.
EV to Sales6.84
EV to EBITDA8.02K
EV to Free Cash Flow-524.82
EV to Operating Cash Flow1.90K
Balance Sheet
AxoGen has $94.57M in cash and marketable securities with $20.07M in debt, giving a net cash position of $74.51M billion.
Cash & Marketable Securities$94.57M
Total Debt$20.07M
Net Cash$74.51M
Net Cash Per Share$1.39
Tangible Book Value Per Share$2.65
Margins
Gross margin is 74.56%, with operating margin of -3.49%, and net profit margin of -6.97%.
Gross Margin74.56%
Operating Margin-3.49%
Pretax Margin-6.97%
Net Profit Margin-6.97%
EBITDA Margin0.09%
EBIT Margin-3.55%
Analyst Forecast
The average price target for AxoGen is $55.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$55.17
Price Target Upside39.70% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast23.57%
EPS Growth Forecast-543.50%